Overview

Long-Term Oral Acyclovir Usage to Prevent Herpes Zoster Virus Infection After Bone Marrow Transplant

Status:
Completed
Trial end date:
2004-07-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to prevent reactivation of herpes zoster during the first year after transplant.
Phase:
Phase 3
Details
Lead Sponsor:
Fred Hutchinson Cancer Research Center
Collaborators:
Burroughs Wellcome
National Institutes of Health (NIH)
Treatments:
Acyclovir